StockIQpro
NASDAQ:KOD

Kodiak Sciences Inc.

Track all markets on TradingView
Track all markets on TradingView

Kodiak Sciences Inc. reported net income of −$230.0M in fiscal 2025. Free cash flow was −$136.5M, and the diluted share count rose 1.2%.Summary generated from Kodiak Sciences Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−149.5%
Debt / equityn/a
Free cash flow−$136.5M
FCF marginn/a
Share count change+1.2%

Financials

Fiscal years, $M
Item20212022202320242025
Revenuen/an/an/an/an/a
Operating income−267−341−277−187−234
Net income−267−334−260−176−230
Free cash flow−199−243−196−118−137

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)